文献速递牙周病

NAMPT是类风湿关节炎介导的牙周炎症的关键调节因子

NAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation.
PubMed 文献 · J Dent Res · 2017-02-06

研究在胶原诱导性关节炎(CIA)和肿瘤坏死因子-α转基因(TNF-α TG)小鼠模型中验证类风湿关节炎(RA)是否介导类牙周炎表型,并探索烟酰胺磷酸核糖转移酶(NAMPT)的作用。结果显示RA小鼠模型牙周膜组织和人牙周膜细胞中NAMPT表达上调,细胞内NAMPT(iNAMPT)抑制可减轻CIA小鼠牙周组织损伤。

要点

  • CIA和TNF-α TG小鼠模型中出现牙周炎症和牙槽骨丢失。
  • RA小鼠模型牙周膜组织及IL1β/TNF-α刺激的人牙周膜细胞中NAMPT表达上调。
  • FK866或烟酰胺抑制iNAMPT可抑制IL1β或Ad-Nampt诱导的分解代谢因子上调,重组NAMPT蛋白或eNAMPT阻断抗体无效。

核心结论

  • 实验结果验证了RA与牙周炎症在小鼠RA模型中的共存,提示牙周膜细胞中的iNAMPT通过调节IL6、IL8、CCL5、COX-2、MMP1和MMP3等分解代谢基因表达水平,在RA介导的牙周炎症发病机制中起关键作用。

研究设计与样本

  • 研究采用胶原诱导性关节炎(CIA)和基因修饰的肿瘤坏死因子-α转基因(TNF-α TG)小鼠模型,以及人牙周膜细胞体外实验。

主要发现

  • 在CIA和TNF-α TG小鼠模型中报告了牙周炎症和牙槽骨丢失。
  • 在RA小鼠模型的牙周膜组织中以及经IL1β和TNF-α刺激的人牙周膜细胞中,NAMPT表达明显上调。
  • 用Nampt合成腺病毒载体(Ad-Nampt)过表达NAMPT后,牙周膜细胞中IL6、IL8、CCL5、COX-2、MMP1和MMP3表达增加。
  • 在牙周膜细胞中,用细胞内NAMPT(iNAMPT)抑制剂FK866或sirtuin抑制剂烟酰胺抑制NAMPT,可抑制IL1β或Ad-Nampt诱导的分解代谢因子上调;而重组NAMPT蛋白处理或用阻断抗体阻断细胞外NAMPT(eNAMPT)则无此作用。
  • 在CIA小鼠中,腹腔或牙龈内注射FK866抑制NAMPT,在RA条件下抑制了牙周组织损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent studies have indicated a potential correlation between rheumatoid arthritis (RA) and periodontal inflammation. We undertook this study to verify whether RA mediates periodontitis-like phenotypes in experimental mouse models of RA and to explore the role of nicotinamide phosphoribosyltransferase (NAMPT) in periodontal inflammation during RA pathogenesis. Periodontal inflammation and alveolar bone loss have been reported in mice with collagen-induced arthritis (CIA) and in genetically modified tumor necrosis factor-α (TNF-α) transgenic (TG) mouse models. Among the adipokines examined in our study, NAMPT expression was markedly upregulated in the periodontal ligament (PDL) tissues in RA mouse models and in human PDL cells stimulated by the proinflammatory cytokines, interleukin (IL) 1β and TNF-α. When NAMPT was overexpressed with the Nampt-synthesizing adenovirus vector (Ad- Nampt), the PDL cells exhibited an increased expression of cytokines (IL6), chemokines (IL8 and chemokine [C-C motif] ligand 5 [CCL5]), inflammatory mediators (cyclooxygenase 2 [COX-2]), and matrix-degrading enzymes (matrix metalloproteinase [MMP] 1 and MMP3). Inhibition of NAMPT by the intracellular NAMPT (iNAMPT) inhibitor, FK866, or by the sirtuin inhibitor, nicotinamide, in PDL cells led to inhibition of the IL1β or Ad- Nampt-induced upregulation of catabolic factors, whereas treatment with recombinant NAMPT protein or blockade of extracellular NAMPT (eNAMPT) with blocking antibody did not. Moreover, NAMPT inhibition by the intraperitoneal or intragingival injection of FK866 in CIA mice inhibited periodontal tissue damage, under conditions of RA. Thus, our results verified the co-occurrence of RA and periodontal inflammation using experimental mouse models of RA, suggesting that iNAMPT in PDL cells plays a pivotal role in the pathogenesis of RA-mediated periodontal inflammation by regulating the expression levels of catabolic genes, such as IL6, IL8, CCL5, COX-2, MMP1, and MMP3.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Kim D, Lee G, Huh YH, et al. NAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation. J Dent Res. 2017. PMID: 28165872. doi:10.1177/0022034517690389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。